Will the Puretech Health share price run continue?

In this article we will quickly re-cap the broker forecasts for Puretech Health (LON:PRTC).

The Puretech Health share price has risen by 7.30% over the past month and it’s currently trading at 185.2p. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Puretech Health currently has:

• 3 Buy recommendations

• 0 Hold recommendations

• 0 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO LON:PRTC »

Questioning broker positivity

At its current price of 185.2p, shares in Puretech Health are trading at a discount of -55.3% to its 52 week high price. The 1-year performance of the shares has been -53.5%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Puretech Health it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Puretech Health that you can find out about here.